Cargando…
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
AIMS/HYPOTHESIS: Glucagon-like peptide 1 receptor agonists (GLP-1 RA) such as exenatide are used as monotherapy and add-on therapy for maintaining glycaemic control in patients with type 2 diabetes mellitus. The current study investigated the safety and efficacy of once-weekly PB-119, a PEGylated ex...
Autores principales: | Ji, Linong, Du, Ying, Xu, Min, Zhou, Xiangjun, Mo, Zhaohui, Ma, Jianhua, Li, Jiarui, Li, Yufeng, Lin, Jingna, Wang, Yanjun, Yang, Jing, Song, Weihong, Jin, Hui, Pang, Shuguang, Liu, Hui, Li, Ping, Liu, Jie, Yao, Minxiu, Li, Wenhui, Jiang, Xiaohong, Shen, Feixia, Geng, Houfa, Zhou, Haifeng, Ran, Jianmin, Lei, Minxiang, Du, Yinghong, Ye, Shandong, Guan, Qingbo, Lv, Wenshan, Tan, Huiwen, Chen, Tao, Yang, Jinkui, Qin, Guijun, Li, Shiyun, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012337/ https://www.ncbi.nlm.nih.gov/pubmed/33687487 http://dx.doi.org/10.1007/s00125-021-05392-9 |
Ejemplares similares
-
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
por: Ji, Linong, et al.
Publicado: (2021) -
PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients
por: Liu, Xu, et al.
Publicado: (2023) -
Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013) -
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019) -
Upregulation and biological function of transmembrane protein 119 in osteosarcoma
por: Jiang, Zhen-Huan, et al.
Publicado: (2017)